Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

Globus Medical has completed its acquisition of Nevro, broadening its market presence in musculoskeletal solutions.

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.

Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its ...

The market includes spinal cord stimulation (SCS) systems as well as peripheral nerve stimulation (PNS) systems- SAN ...

Nevro NVRO is well-poised for growth in ... However, concerns regarding softness in the spinal cord stimulation (SCS) market and dependence on third-party payers persist. This Zacks Rank #2 ...

Nevro Corp. engages in the development of ... It develops and commercializes the senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic ...